Vivek Subbiah/LinkedIn
Jun 3, 2025, 14:41
Vivek Subbiah: What a Fantastic ASCO POST 2025 Editorial Board Meeting
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared on LinkedIn:
“Wow! What a fantastic ASCO-POST editorial board meeting at ASCO 25 energized by visionary leaders in oncology Jame Abraham, George Demetri, Omid Hamid, Allison Betof Warner et al.
Phenomenal discussions on how to disseminate cutting-edge cancer research updates for all. Nothing beats face-to-face meetings and real-time inputs!”
More posts featuring ASCO 2025 on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 29, 2025, 12:42
Jun 29, 2025, 12:38
Jun 29, 2025, 11:09
Jun 29, 2025, 10:35
Jun 29, 2025, 10:32